Fecal microbiota transplantation: present and future
Clinical Endoscopy · 30.05.2025 · 58 (3) · 352-359
DOI: 10.5946/ce.2024.270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Endoscopy, erschienen am 30.05.2025. Verfasst von Ra Ri Cha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Jinju, Korea. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Gyeongsang National University Fund.
Abstract (Originalsprache)
Fecal microbiota transplantation (FMT) involves transplanting fecal matter from healthy donors into patients with gut dysbiosis to restore microbial balance. It has been proven to be highly effective in treating recurrent Clostridioides difficile infection (CDI), and United States Food and Drug Administration-approved microbiome-based therapies, such as REBYOTA (fecal microbiota live-jslm) and VOWST (fecal microbiota spores live-brpk), offer promising treatment options. Although FMT is widely used to treat recurrent CDI, its use in gastrointestinal and metabolic diseases remains limited. Future research directions include optimizing donor selection, understanding microbial mechanisms, and exploring the potential of FMT for treating other diseases. Ongoing research not only aims to broaden its indications but also improves its safety and efficacy. Emerging therapies such as VE303 (Vedanta) are being studied to refine treatment approaches and expand the use of microbiota-based therapies. Further studies are needed to standardize guidelines, improve patient outcomes, and better define the role of FMT in the treatment of diseases beyond recurrent CDI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Förderung
- Gyeongsang National University Fund
Zitieren
APA
Cha, R. R., & Sonu, I. (2025). Fecal microbiota transplantation: present and future. Clinical Endoscopy, 58(3), 352-359. https://doi.org/10.5946/ce.2024.270
Vancouver
Cha RR, Sonu I. Fecal microbiota transplantation: present and future. Clinical Endoscopy. 2025;58(3):352-359. doi:10.5946/ce.2024.270
BibTeX
@article{Cha2025,
author = {Cha, Ra Ri and Sonu, Irene},
title = {Fecal microbiota transplantation: present and future},
journal = {Clinical Endoscopy},
year = {2025},
volume = {58},
number = {3},
pages = {352--359},
doi = {10.5946/ce.2024.270}
}
EUVIMED